This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.55, marking a +1.36% move from the previous day.
Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
CVS Health (CVS) reachead $51.96 at the closing of the latest trading day, reflecting a -0.35% change compared to its last close.
Will UNH, HUM & CVS be the Top Beneficiaries of the $21B MA Boom?
by Kaibalya Pravo Dey
The government's payment rate directly impacts insurers' pricing, plan benefits and overall profitability.
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs
by Zacks Equity Research
The report comes at a time when insurers are grappling with rising medical costs.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Big Gains Ahead for Medicare Advantage Sellers as Payments Set to Grow
by Kaibalya Pravo Dey
As the largest MA plan sellers, UnitedHealth, Humana and CVS Health collectively account for nearly 60% of the market.
Walgreens Boots Alliance (WBA) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 37.84% and 6.41%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) Stock Moves -0.09%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $45.78 in the latest trading session, marking a -0.09% move from the prior day.
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Should Walgreens Stock Be in Your Portfolio Before Q1 Earnings?
by Moumi Mondal
WBA's fiscal 2025 first-quarter results are expected to continue to reflect a soft U.S. Retail Pharmacy performance.
CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?
by Urmimala Biswas
CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the resumption of member redeterminations.
CVS Health (CVS) Stock Moves -0.96%: What You Should Know
by Zacks Equity Research
The latest trading day saw CVS Health (CVS) settling at $44.49, representing a -0.96% change from its previous close.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Should You Retain Federal Realty Stock in Your Portfolio Now?
by Zacks Equity Research
FRT is set to gain from a diversified portfolio with a focus on essential retail and mixed-use assets. Higher e-commerce adoption and high interest expense ail.
Why CVS Health (CVS) Outpaced the Stock Market Today
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $44.36, marking a +1.32% move from the previous day.
Reasons to Ratain CVS Stock in Your Portfolio Now
by Zacks Equity Research
Investors feel optimistic about CVS Health's 2025 roadmap. Yet, poor macroeconomic conditions are concerning.
CVS Health (CVS) Stock Moves -0.42%: What You Should Know
by Zacks Equity Research
The latest trading day saw CVS Health (CVS) settling at $49.37, representing a -0.42% change from its previous close.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
by Zacks Equity Research
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Rising Costs, Denied Claims and a Tragedy: Health Insurers Stumble
by Kaibalya Pravo Dey
Shares of UnitedHealth, Centene, Elevance Health and CVS Health have witnessed significant declines since last Wednesday.
CVS' High Utilization & MBR to Cut 2024 Profits: Is the Stock a Sell?
by Urmimala Biswas
The persistently elevated utilization of medical services is significantly putting pressure on CVS Health's Health Care Benefits segment.
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Why Is CVS Health (CVS) Down 0.4% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.